532523:BOM
Biocon Ltd
350,00 INR
arrow_downward
-0,43%(-1,50) 1D
16 ოქტ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
352,95 INR
High
352,95 INR
Low
348,10 INR
Mkt. cap
568,79 მლრ.
Avg. vol.
692,61 ათ.
Volume
668,34 ათ.
Dividend
0,14%
Quarterly dividend
0,13 INR
Ex-dividend date
3 ივლ. 2026
P/E ratio
103,62
52-wk high
447,00 INR
52-wk low
337,95 INR
EPS
3,38 INR
Shares outstanding
600,00 მლნ.
No. of employees
16 ათ.
Open
352,95 INR
High
352,95 INR
Low
348,10 INR
Mkt. cap
568,79 მლრ.
Avg. vol.
692,61 ათ.
Volume
668,34 ათ.
Dividend
0,14%
Quarterly dividend
0,13 INR
Ex-dividend date
3 ივლ. 2026
P/E ratio
103,62
52-wk high
447,00 INR
52-wk low
337,95 INR
EPS
3,38 INR
Shares outstanding
600,00 მლნ.
No. of employees
16 ათ.
News stories
From web sources and news partners
Simply Wall Street
·
31 წუთის წინ
Freshworks (FRSH) Shares Just Moved, So What Is Going On?
KuCoin
·
21 წუთის წინ
Nasdaq posts its worst weekly decline since June, gold rebounds but faces resistance at 4200
Yahoo Finance
·
14 საათის წინ
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
1 დღის წინ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16,4 ათ.
Founded29 ნოე. 1978
Headquartersბენგალურუ, კარნატაკა, ინდოეთი
Sector-
Websitebiocon.com